Cellular
Restoration
Discover the power of MuseMSCs™ – the body's natural solution for ultimate tissue restoration without genetic modification. A paradigm shift in clinical therapeutics.
• Endogenous pluripotent-like cells residing in perinatal tissues...
• A naturally existing subset of mesenchymal stem cells.
IDENTITY
The Elusive Subpopulation
Multilineage-differentiating stress-enduring (Muse) cells are a unique subpopulation of mesenchymal stem cells (MSCs). They represent a fundamental breakthrough in regenerative medicine, possessing the pluripotency typically associated with embryonic cells, but without the ethical dilemmas or tumorigenic risks.
PARADIGM SHIFT
Beyond Conventional MSCs™
The therapeutic potential of conventional MSCs is often limited by their size, survival rate, and differentiation capacity. MuseMSCs™ overcome these critical barriers.
Size & Passage
Conventional MSCs (20-30μm) often get trapped in lung capillaries (pulmonary first-pass effect). MuseMSCs™ (~13μm) pass freely, reaching target organs efficiently.
Stress Tolerance
MuseMSCs™ inherently survive severe stress conditions (hypoxia, low nutrition) that typically cause high mortality in conventional MSCs post-transplantation.
Differentiation
While MSCs are limited to mesenchymal lineages, MuseMSCs™ can differentiate into endodermal, ectodermal, and mesodermal tissues.
Dose Efficiency
Due to high survival and homing capabilities, MuseMSC™ therapies require 10-15x fewer cells than conventional MSC treatments to achieve superior outcomes.
SAFETY PROFILE
Immune Privilege
A universal donor solution. MuseMSCs™ can be administered across HLA mismatches without the need for immunosuppressive therapy.
HLA-G Expression
Expression of HLA-G at 90% similar to the mechanism protecting a fetus from maternal immune rejection, shields MuseMSCs™ from host immune attacks.
No Immunosuppressants
Eliminates the severe side effects and infection risks associated with systemic immunosuppressive drugs typically required for allogeneic transplants.
Off-the-Shelf Therapy
Enables the creation of universal, ready-to-use cellular therapeutics from healthy donors, drastically reducing costs and wait times.
DURABILITY
Long-Term Integration
Unlike traditional therapies that merely provide temporary paracrine effects before dying off, MuseMSCs™ structurally integrate into the host tissue. They survive long-term, differentiating into functional cells that continuously produce healing factors.
• Studies demonstrate functional Muse cell integration and survival for over 12 months post-administration in preclinical models.